Researchers reported a contact-dependent cross-dressing mechanism showing dendritic cells can amplify tebentafusp-mediated T-cell activation against tumor cells. The work links APC behavior to downstream immune effector cytokine production and cytotoxicity, reinforcing tebentafusp’s biology beyond direct targeting and supporting more mechanistic trial design considerations.
Get the Daily Brief